Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Evogene Ltd. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 14 | 18 | +4 |
| Shares | 154.3K | 181.7K | +27.4K (+17.8%) |
| Value | $176.1K | $199.8K | +$23.8K (+13.5%) |
New holders (5)
Institutions that held Evogene Ltd. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 22,684 | $25.0K | 0.00% |
| Daytona Street Capital LLC | 9,586 | $10.5K | 0.01% |
| SHP Wealth Management | 65 | $72 | 0.00% |
| Russell Investments Group, Ltd. | 1 | $1 | 0.00% |
| Farther Finance Advisors, LLC | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held Evogene Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Two Sigma Securities, LLC | 11,406 | $13.0K |